Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,489 papers from all fields of science
Search
Sign In
Create Free Account
TAK-491
Known as:
TAK 491
, TAK491
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
azilsartan medoxomil
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The Angiotensin Receptor Blocker, Azilsartan Medoxomil (TAK-491), Suppresses Vascular Wall Expression of Plasminogen Activator Inhibitor Type-I Protein Potentially Facilitating the Stabilization of…
C. French
,
A. T. Zaman
,
B. Sobel
Journal of Cardiovascular Pharmacology
2011
Corpus ID: 25176998
Increased expression of plasminogen activator inhibitor type-I (PAI-1) in vessel walls seems to accelerate atherosclerosis…
Expand
2011
2011
INHIBITION OF THE ANGIOTENSIN II TYPE-1 (AT-1) RECEPTOR BY THE ANGIOTENSIN RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL (TAK-491) SUPPRESSES AORTIC EXPRESSION OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-I (PAI…
C. French
,
P. Q. Baumann
,
D. Neimane
,
Keara L McElroy-Yaggy
,
Tarikuz Zaman
,
B. Sobel
2011
Corpus ID: 71643550
2010
2010
Additive Effect of TAK-491, a New Angiotensin Receptor Blocker, and Pioglitazone, in Reducing Myocardial Infarct Size
Y. Ye
,
Kyle T. Keyes
,
Chong Zhang
,
J. Perez-Polo
,
Yu Lin
,
Y. Birnbaum
Cardiovascular Drugs and Therapy
2010
Corpus ID: 26277932
PurposeWe assessed the effects of TAK-491 (a newly designed potent and selective ARB) alone and in combination with pioglitazone…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE